{"nct_id":"NCT00552396","title":"An Open-label, Dose-escalation Safety and Tolerability Trial Assessing Anti-KIR (1-7F9) in Subjects With Multiple Myeloma","status":"COMPLETED","status_verified_date":"2016-03","start_date":"2007-05","start_date_type":null,"primary_completion_date":"2011-01","primary_completion_date_type":"ACTUAL","completion_date":"2011-01","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["IPHA"]}